Nova Eye Medical Company Description
Nova Eye Medical Limited designs, develops, distributes, markets, sells, and services surgical devices for the treatment of glaucoma.
The company offers iTrack, a surgical system for the reduction in intraocular pressure (IOP) in adult patients with open-angle glaucoma; iTrack Advance, a natural ocular drainage system; Molteno3, a glaucoma drainage device to treat patients with severe or complex glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration.
It operates in Australia, the United States, Europe, the Asia Pacific, and internationally. The company was formerly known as Ellex Medical Lasers Limited and changed its name to Nova Eye Medical Limited in July 2020.
Nova Eye Medical Limited was founded in 1985 and is headquartered in Kent Town, Australia.

| Country | Australia |
| Founded | 1970 |
| Industry | Medical Devices |
| Sector | Healthcare |
| CEO | Thomas Spurling |
Contact Details
Address: 107 Rundle Street Kent Town, SA SA Australia | |
| Phone | 61 8 8362 0193 |
Stock Details
| Ticker Symbol | EYE |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU0000094252 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Victor Previn | Founder and Chairman |
| Thomas H. Spurling AM, BSc (Hons), FRACI, FTSE, Ph.D. | MD and Executive Director |
| Michael Southard | Executive Director |
| Kimberley Menzies | Chief Financial Officer |
| Mark Flynn | Investor Relations |
| Kate Hunt | Chief Commercial Officer |
| Joe Bankovich | President of Global Sales |
| Joaquin V. Wolff | President of Ellex iTrack |
| Simon Jeremy Newton Gray BEc, C.A. | Company Secretary |
| Jordan Possingham | Financial Controller |